News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi (France) (SAN.PA)'s Q3 China Revenues Increase at Slower 5% Rate


11/1/2013 9:30:08 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

October 31, 2013 -- Sanofi’s global revenues dropped 6.7% to $11.6 billion in Q3, a disappointment. The company said a modest 2.8% increase in emerging markets sales was not enough to offset revenue shortfalls from drugs that have lost their patent protection. Sanofi’s China revenues actually rose during the quarter: they were up 5% to $477 million, though 5% represents a smaller increase than the double-digit percentage that has been the norm. More details....

Stock Symbol: (NYSE: SNY)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES